SensArs is a medtech company specializing in neuromodulation technologies for the peripheral nervous system. Its product, SENSY, is a device to restore sensory feedback to leg amputees through their prosthesis. It is implanted within the residual nerves, or healthy part of the nerves, restoring the natural-like flow of the neural sensory information, which enables patients to feel natural sensations from the missing or non-functional limb.
|Employees (est.) (Feb 2020)||1|
SensArs total Funding
SensArs latest funding size
Time since last funding
|2 years ago|
|EASME - EU Executive Agency for SMEs, Venture Kick|
SensArs has 127 Twitter Followers. The number of followers has increased 3.1% month over month and increased 12.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was SensArs founded?
SensArs was founded in 2014.
How many employees does SensArs have?
SensArs has 1 employees.
Who are SensArs competitors?
Competitors of SensArs include ADORA, C. R. Bard and Cadence Neuroscience.
Where is SensArs headquarters?
SensArs headquarters is located at Rue du Maupas 38, Lausanne.
Where are SensArs offices?
SensArs has an office in Lausanne.
How many offices does SensArs have?
SensArs has 1 office.
Receive alerts for 300+ data fields across thousands of companies